Rekah Pharmaceutical Industry Ltd. (REKA.TA)
ILA 1400.0
(0.43%)
ILA 1400.0
(0.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 321.66 Million | 292.39 Million | 263.95 Million | 265.47 Million | 196.49 Million | 207.82 Million |
| Cost of Revenue | 241.46 Million | 213.68 Million | 198.78 Million | 196.82 Million | 135.38 Million | 141.08 Million |
| Gross Profit | 80.2 Million | 78.7 Million | 65.16 Million | 68.64 Million | 61.11 Million | 66.74 Million |
| Operating Expenses | 79.67 Million | 63.53 Million | 51.47 Million | 46.82 Million | 48.44 Million | 52.35 Million |
| Selling, General and Administrative Expenses | 71.04 Million | 12.61 Million | 10.04 Million | 8.25 Million | 8.82 Million | 10.16 Million |
| Research and Development Expenses | 3.77 Million | 3.23 Million | 2.08 Million | 1.54 Million | 1.7 Million | 2.58 Million |
| Other Expenses | - | 47.68 Million | 39.34 Million | 37.02 Million | 37.91 Million | 39.6 Million |
| Cost and Expenses | 321.13 Million | 277.22 Million | 250.25 Million | 243.64 Million | 183.83 Million | 193.44 Million |
| Operating Income | 2.9 Million | 13.25 Million | 14.14 Million | 20.92 Million | 11.53 Million | 14.22 Million |
| Interest Expense | - | 5.64 Million | 5.63 Million | 5.81 Million | 5.1 Million | 4.3 Million |
| Income Tax Expense | 138 Thousand | 2.4 Million | 1.09 Million | 3.35 Million | 1.78 Million | 3.06 Million |
| Earnings before Tax | -7.05 Million | 357 Thousand | 7.71 Million | 14.15 Million | 4.54 Million | 9.91 Million |
| Net Income | -6.91 Million | -2.04 Million | 6.62 Million | 10.79 Million | 2.75 Million | 7.02 Million |
| Earnings Per Share Basic | -0.61 | -0.18 | 0.58 | 0.95 | 0.24 | 0.64 |
| Earnings Per Share Diluted | -0.61 | -0.18 | 0.58 | 0.95 | 0.24 | 0.64 |
| Weighted Average Shares Outstanding | 11.32 Million | 11.33 Million | 11.41 Million | 11.41 Million | 11.41 Million | 10.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.41 Million | 11.41 Million | 11.41 Million | 11.41 Million | 11.41 Million | 10.91 Million |
| Gross Margin | 0.25 | 0.27 | 0.25 | 0.26 | 0.31 | 0.32 |
| EBIT Margin | 0.08 | 0.14 | 0.14 | 0.15 | 0.14 | 0.12 |
| Profit Margin | -0.02 | -0.01 | 0.03 | 0.04 | 0.01 | 0.03 |
| EBITDA | 26.02 Million | 40.23 Million | 36.2 Million | 39.68 Million | 26.55 Million | 26.41 Million |
| Earnings Before Tax Margin | 0.01 | 0.05 | 0.05 | 0.08 | 0.06 | 0.07 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 68.69 Million | 89.67 Million | 321.66 Million | 86.04 Million | 79.95 Million | 76.66 Million |
| Cost of Revenue | 55.07 Million | 66.73 Million | 241.46 Million | 65.81 Million | 61.29 Million | 55.68 Million |
| Gross Profit | 13.61 Million | 22.93 Million | 80.2 Million | 20.23 Million | 18.66 Million | 20.98 Million |
| Operating Expenses | 18.51 Million | 19.95 Million | 79.67 Million | 20.98 Million | 20.19 Million | 19.05 Million |
| Selling, General and Administrative Expenses | 17.47 Million | 18.94 Million | - | 18.37 Million | 19.23 Million | 18.12 Million |
| Research and Development Expenses | 1.04 Million | 1.01 Million | - | 933 Thousand | 961 Thousand | 926 Thousand |
| Other Expenses | 22.51 Million | -218 Thousand | - | - | -717 Thousand | -234 Thousand |
| Cost and Expenses | 73.59 Million | 86.69 Million | 321.13 Million | 86.8 Million | 81.48 Million | 74.73 Million |
| Operating Income | 17.61 Million | 2.76 Million | 2.9 Million | -68 Thousand | -2.24 Million | 1.69 Million |
| Interest Expense | 2.33 Million | 2.53 Million | - | - | 2.38 Million | 2.4 Million |
| Income Tax Expense | 3.56 Million | -599 Thousand | 138 Thousand | 1.15 Million | 504 Thousand | 90 Thousand |
| Earnings before Tax | 15.56 Million | 601 Thousand | -7.05 Million | -2.06 Million | -4.98 Million | -1 Million |
| Net Income | 11.99 Million | 1.2 Million | -6.91 Million | -901 Thousand | -5.49 Million | -1.09 Million |
| Earnings Per Share Basic | 1.05 | 0.11 | - | -0.08 | -0.48 | -0.10 |
| Earnings Per Share Diluted | 1.05 | 0.11 | - | -0.08 | -0.48 | -0.10 |
| Weighted Average Shares Outstanding | 11.42 Million | 10.9 Million | 11.32 Million | 10.99 Million | 11.41 Million | 10.95 Million |
| Weighted Average Shares Outstanding (Diluted) | 11.42 Million | 10.9 Million | 11.41 Million | 11.64 Million | 11.43 Million | 10.95 Million |
| Gross Margin | 0.20 | 0.26 | 0.25 | 0.24 | 0.23 | 0.27 |
| EBIT Margin | 0.38 | 0.12 | - | 0.01 | 0.07 | 0.12 |
| Profit Margin | 0.17 | 0.01 | -0.02 | -0.01 | -0.07 | -0.01 |
| EBITDA | 26.29 Million | 11.2 Million | - | 953 Thousand | 5.51 Million | 9.26 Million |
| Earnings Before Tax Margin | 0.26 | 0.03 | 0.01 | -0.00 | -0.03 | 0.02 |
0K5R
AME
AMCR
TTT
YEXT
MACF